Skip to main content
. 2021 Feb 3;137:111313. doi: 10.1016/j.biopha.2021.111313

Fig. 8.

Fig. 8

(A) Representative peptidomimetic 3CLpro inhibitors. (B) Chemical structures of α-ketoamide inhibitors 7-10. The coloured circles and arrows show the specific modifications at each development step.